Pharma Industry News

Positive results for Eli Lilly’s Taltz in late stage non-radiographic axial spondyloarthritis trial

Taltz is also approved to treat adults with moderate-to-severe plaque psoriasis.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]